{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-23-002359","form_type":"8-K","ticker":"SNOA","cik":"0001367083","company_name":"Sonoma Pharmaceuticals, Inc.","filed_at":"2023-04-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.579944+00:00","generated_at":"2026-06-17T02:30:47.724817+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Sonoma Pharmaceuticals CFO Chad White resigns; Jerry Dvonch named interim CFO","bullets":["Chad White resigned as CFO effective April 7, 2023; unvested options forfeited.","Board appointed Jerry Dvonch (former CFO, Sept 2020–Nov 2022) as interim CFO.","Dvonch to receive $250/hour plus $30,000 in restricted stock vesting July 15 and Aug 15, 2023.","Consulting agreement runs until filing of Q1 FY2024 10-Q (quarter ending June 30, 2023).","Dvonch's vested equity awards extended by one month per month of service under the agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-23-002359","json":"https://secwatch.observer/filing/0001683168-23-002359.json","markdown":"https://secwatch.observer/filing/0001683168-23-002359.md","text":"https://secwatch.observer/filing/0001683168-23-002359.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1367083/000168316823002359/0001683168-23-002359-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1367083/000168316823002359/sonoma_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T02:30:47.724817+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3abcbded00","claim":"Chad White resigned as Chief Financial Officer at Sonoma Pharmaceuticals, Inc..","evidence_excerpt":"Effective April 7, 2023, Chad White resigned as our Chief Financial Officer, and our Board of Directors appointed Jerry Dvonch as our interim Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316823002359/0001683168-23-002359-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"dd845c7184","claim":"Jerry Dvonch was appointed as interim Chief Financial Officer at Sonoma Pharmaceuticals, Inc..","evidence_excerpt":"Effective April 7, 2023, Chad White resigned as our Chief Financial Officer, and our Board of Directors appointed Jerry Dvonch as our interim Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316823002359/0001683168-23-002359-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"interim Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}